CRISPR Therapeutics

URI: https://gptkb.org/entity/CRISPR_Therapeutics
GPTKB entity
Statements (75)
Predicate Object
gptkbp:instance_of gptkb:biotechnology
gptkbp:acquisition gptkb:TCR2_Therapeutics
gptkbp:ceo gptkb:Samarth_Kulkarni
gptkbp:clinical_trial gptkb:sickle_cell_disease
gptkb:anemia
therapeutics
gptkbp:collaboration gptkb:Bristol-Myers_Squibb
gptkb:Harvard_University
gptkb:University_of_California,_Berkeley
gptkb:Vertex_Pharmaceuticals
gptkbp:collaborations gptkb:Emory_University
gptkb:UCLA
gptkb:University_of_Ottawa
gptkb:University_of_Montreal
gptkb:York_University
gptkb:Mount_Sinai_Health_System
gptkb:University_of_Toronto_Mississauga
gptkb:University_of_Newfoundland
gptkb:Mc_Gill_University
gptkb:Duke_University
gptkb:Harvard_Medical_School
gptkb:Johns_Hopkins_University
gptkb:Stanford_University
gptkb:University_of_British_Columbia
gptkb:University_of_Calgary
gptkb:University_of_California,_San_Francisco
gptkb:University_of_Chicago
gptkb:University_of_Michigan
gptkb:University_of_Pennsylvania
gptkb:University_of_Toronto
gptkb:University_of_Virginia
gptkb:University_of_Washington
gptkb:University_of_Manitoba
gptkb:University_of_Southern_California
gptkb:Weill_Cornell_Medicine
gptkb:Yale_University
gptkb:University_of_Regina
gptkb:Cleveland_Clinic
gptkb:Northwestern_University
gptkb:Simon_Fraser_University
gptkb:University_of_Alberta
gptkb:University_of_Florida
gptkb:MIT
gptkb:University_of_New_Brunswick
gptkb:University_of_Saskatchewan
gptkb:University_of_Toronto_Scarborough
gptkb:Scripps_Research_Institute
gptkb:University_of_Prince_Edward_Island
gptkbp:focus gene editing
gptkbp:focus_area gptkb:gene_therapy
gptkb:Cell
regenerative medicine
gptkbp:founded gptkb:2013
gptkbp:founder gptkb:Emmanuelle_Charpentier
gptkbp:funding gptkb:venture_capital
gptkbp:goal develop transformative gene-based medicines
gptkbp:has_advisory_board leading scientists
gptkbp:headquarters gptkb:Basel,_Switzerland
https://www.w3.org/2000/01/rdf-schema#label CRISPR Therapeutics
gptkbp:instruction_set gptkb:CTX110
gptkb:CTX001
gptkb:CTX120
CTX130
gptkbp:invention gptkb:CRISPR_technology
gptkbp:ipo gptkb:2016
gptkbp:market_cap approximately $1 billion
gptkbp:partnership gptkb:Regeneron_Pharmaceuticals
gptkbp:research_areas gptkb:Oncology
genetic disorders
autoimmune diseases
gptkbp:stock_exchange gptkb:NASDAQ
gptkbp:stock_symbol CRSP
gptkbp:technology gptkb:CRISPR-Cas9
gptkbp:bfsParent gptkb:Vertex_Pharmaceuticals
gptkbp:bfsLayer 4